SCARTOZZI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.354
AS - Asia 2.389
EU - Europa 1.582
AF - Africa 95
SA - Sud America 88
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.234
CN - Cina 1.676
IT - Italia 471
FR - Francia 234
DE - Germania 205
JP - Giappone 194
GB - Regno Unito 131
IN - India 99
ES - Italia 89
CA - Canada 84
IE - Irlanda 70
TW - Taiwan 70
HK - Hong Kong 63
KR - Corea 61
VN - Vietnam 49
AU - Australia 42
CO - Colombia 39
CZ - Repubblica Ceca 39
EG - Egitto 39
SE - Svezia 36
RU - Federazione Russa 35
NL - Olanda 34
ZA - Sudafrica 34
RO - Romania 33
TR - Turchia 33
FI - Finlandia 23
BE - Belgio 21
GR - Grecia 21
PT - Portogallo 21
SG - Singapore 21
ID - Indonesia 20
BR - Brasile 19
CH - Svizzera 19
IR - Iran 16
LT - Lituania 16
MX - Messico 16
MY - Malesia 15
CL - Cile 14
DK - Danimarca 14
UA - Ucraina 14
AR - Argentina 13
PH - Filippine 12
TH - Thailandia 11
NZ - Nuova Zelanda 10
PA - Panama 10
PL - Polonia 10
AT - Austria 9
LB - Libano 9
GT - Guatemala 8
HU - Ungheria 8
IQ - Iraq 8
NO - Norvegia 8
MA - Marocco 6
MK - Macedonia 6
SA - Arabia Saudita 6
DZ - Algeria 5
IL - Israele 5
MO - Macao, regione amministrativa speciale della Cina 5
RS - Serbia 5
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
NG - Nigeria 3
PK - Pakistan 3
TZ - Tanzania 3
UG - Uganda 3
BG - Bulgaria 2
EU - Europa 2
LV - Lettonia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
HR - Croazia 1
JO - Giordania 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 8.564
Salva come PNG Salva come JPEG
Città #
Fairfield 615
Houston 429
Woodbridge 336
Ashburn 329
Seattle 312
Santa Cruz 221
Beijing 202
Ann Arbor 194
Buffalo 192
Cambridge 188
Wilmington 163
Shanghai 149
Guangzhou 128
Wuhan 114
Nanjing 72
Changsha 65
Des Moines 62
Dublin 62
Chengdu 59
Hangzhou 58
San Diego 58
Jinan 48
Tokyo 45
Chicago 44
Dong Ket 44
Taipei 43
Milan 42
Shenyang 38
Paris 34
Rome 33
Las Vegas 32
Ottawa 32
Los Angeles 31
Zhengzhou 31
Phoenix 29
Munich 28
Seoul 28
Stockholm 28
Central District 27
Muizenberg 26
Boardman 25
Chongqing 24
Bremen 23
Changchun 23
Mountain View 23
Bari 22
Bengaluru 22
Clearwater 22
Silver Spring 22
Medellín 20
Guangdong 18
Helsinki 18
Toronto 18
Fuzhou 17
Lanzhou 17
Suzhou 17
New York 16
Central 15
Harbin 15
London 15
Xian 15
Cairo 14
Henderson 14
Baotou 13
Bologna 13
Mumbai 13
Nanchang 13
Scranton 13
Cluj-napoca 12
Duncan 12
Mainz 12
Messina 12
Modena 12
Riva 12
Hebei 11
Jakarta 11
Rochester 11
Singapore 11
Tianjin 11
Barcelona 10
Lake Forest 10
Philadelphia 10
Pilsen 10
Fontenay-sous-bois 9
Menlo Park 9
Nanning 9
Plaza 9
Providence 9
San Francisco 9
Ankara 8
Athens 8
Dallas 8
Dearborn 8
Istanbul 8
Napoli 8
San Jose 8
Verona 8
Ürümqi 8
Berlin 7
Boston 7
Totale 5.478
Salva come PNG Salva come JPEG
Nome #
Immunotherapy for colorectal cancer: where are we heading?, file e31e124d-b6fa-987f-e053-3705fe0a095a 1.125
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma, file e31e124d-b080-987f-e053-3705fe0a095a 773
The Italian Rare Pancreatic Exocrine Cancer Initiative, file e31e124d-b0ed-987f-e053-3705fe0a095a 666
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis, file e31e124d-b768-987f-e053-3705fe0a095a 649
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale, file e31e124d-b6ff-987f-e053-3705fe0a095a 611
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations, file e31e124d-bc78-987f-e053-3705fe0a095a 531
Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma, file e31e124d-b6f6-987f-e053-3705fe0a095a 487
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol, file e31e124d-b766-987f-e053-3705fe0a095a 470
Multimodal treatment of resectable pancreatic ductal adenocarcinoma, file e31e124d-b6fc-987f-e053-3705fe0a095a 416
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib, file e31e124d-b994-987f-e053-3705fe0a095a 377
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma, file e31e124d-b076-987f-e053-3705fe0a095a 367
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial, file e31e124d-497a-987f-e053-3705fe0a095a 240
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?, file e31e124d-b76b-987f-e053-3705fe0a095a 183
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials, file e31e124d-b7df-987f-e053-3705fe0a095a 178
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New, file e31e124d-ba98-987f-e053-3705fe0a095a 161
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier), file e31e124d-b0ea-987f-e053-3705fe0a095a 158
Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib, file e31e124d-b06c-987f-e053-3705fe0a095a 156
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study, file e31e124d-b764-987f-e053-3705fe0a095a 151
Efficacy of sorafenib in BRAF-mutated nonsmall- cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report, file e31e124d-ba96-987f-e053-3705fe0a095a 149
Immunotherapeutic approaches for hepatocellular carcinoma, file e31e124d-b074-987f-e053-3705fe0a095a 142
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer, file e31e124d-b777-987f-e053-3705fe0a095a 139
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin, file e31e124d-b7da-987f-e053-3705fe0a095a 136
Antiangiogenic agents after first line and sorafenib plus chemoembolization: A systematic review, file e31e124d-b705-987f-e053-3705fe0a095a 134
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study, file e31e124d-b996-987f-e053-3705fe0a095a 132
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC), file e31e124d-b0b3-987f-e053-3705fe0a095a 129
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy, file e31e124e-ad60-987f-e053-3705fe0a095a 92
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer, file e31e124e-2cbd-987f-e053-3705fe0a095a 80
Immunotherapy for colorectal cancer: where are we heading?, file 0d6b8520-eec0-4366-bad6-36f7263cfbcd 27
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file 86798704-86d5-4851-8107-347f32a002af 1
Totale 8.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019138 0 0 0 0 0 0 0 0 0 4 8 126
2019/20201.880 121 106 60 131 178 194 245 197 229 133 172 114
2020/20212.827 163 192 203 285 273 310 232 252 218 263 250 186
2021/20222.612 304 192 175 365 276 176 169 162 203 117 301 172
2022/20231.225 81 106 217 146 117 171 135 63 79 35 60 15
2023/2024157 10 12 20 13 28 9 28 22 10 5 0 0
Totale 8.860